Morning after pill faces test over access

WASHINGTON Fri Feb 11, 2011 9:21am EST

Related Topics

WASHINGTON (Reuters) - The maker of the Plan B morning-after pill is gearing up for another round with the U.S. Food and Drug Administration over whether the emergency contraceptive can be sold without a prescription for younger women and girls.

Teva Pharmaceutical Industries Ltd earlier this week said it had asked the FDA for permission to sell the drug without any age limits, the latest salvo in a decade-long battle over the pill. Only those 17 and older can buy it now without a doctor's order.

Chief Executive Shlomo Yanai announced the move on Tuesday, calling it "an important milestone" for the product, now sold as one pill called Plan B One-Step.

It is also the latest political challenge for the agency, which was widely criticized for its handling of the pill under the Bush Administration.

Medical and women's groups have sought wider access for Plan B, which Teva acquired in 2008, since 2001. But the effort stalled under President George W. Bush and sparked multiple legal actions and congressional protests that the agency was letting politics trump science.

The FDA allowed limited "behind the counter" sales for women 18 and older in 2006 that required controversial identification checks. It later lowered the limit to age 17.

Plan B, first approved in 1999, contains a higher dose of the hormone progestin that has been widely used in regular birth control pills for decades. It had been sold in a two-pill version taken within 72 hours that now faces generic rivals.

Advocates for such emergency pills say they help reduce unwanted pregnancies or abortions and that quick, easy access for girls and women of all ages is critical for the medicines to work. Conservative critics charge they could lead to promiscuity and sexual abuse.

Women's groups have sued the FDA over its handling of Plan B, and in 2009 the agency was ordered to reconsider its decision. Representatives for the FDA had no immediate comment on the status of its review or Teva's new bid.

It was not immediately clear how the new application would affect exclusivity for Plan B One-Step, which Teva's Yanai said saw higher sales in 2010 but offered no details.

Teva gave the FDA additional data based on a study of actual use of the contraceptive in girls and teen-agers ages 11 to 16. It expects the agency to rule within 10 months.

Planned Parenthood, the Reproductive Health Technologies Project and other supporters said this week they were thrilled Teva was seeking wider access. Several conservative groups that have long opposed the drug either had no immediate comment or could not be immediately reached.

Susan Wood, former head of the FDA's Office of Women's Health who resigned in protest over the agency's handling of the drug, said the agency has long had all the information it needs to rule on wider access.

"This should be straight forward," she told Reuters.

Last year, FDA approved a rival contraceptive pill from Watson Pharmaceuticals Inc and HRA Pharma. Their drug, called ella, works for a longer time after unprotected sex but is only available with a doctor's note.

Plan B has been shown effective for up to three days after intercourse, while ella works for five days.

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (3)
jdl51 wrote:
“Conservative critics charge they could lead to promiscuity and sexual abuse.”

Like there’s not promiscuity and sexual abuse now? Poor excuse to stop someone from using the pill. They’re still living in the make believe world of yesteryear where no one had sex until they were married.

Feb 11, 2011 11:12pm EST  --  Report as abuse
reg.doug wrote:
Considering that pseudoephedrine is a “behind-the-counter” drug, I think it makes sense that this should be too. That level of hormone dose isn’t to be take lightly.

The sexual abuse argument is also legitimate. It is basically the same as for all parental consent laws: It is designed to protect people from making poor decisions.

Feb 12, 2011 3:52pm EST  --  Report as abuse
Fescu wrote:
ROWnine–i reported your comment as abuse for the hateful remarks against gay kids and pretty much everything else. also, it should be taken down for bigotry. all these centuries of religion have obviously taught you hatred, intolerance, narrow-mindedness, and frankly, stupidity, instead of the love and compassion your religion was doubtlessly supposed to teach.

i agree that abstinence, up to a certain level of maturity, is important and that it’s very problematic that kids are having sex at ever earlier ages. there are many causes that lead to early sexual life and they should be addressed, with parents and educators at the top of the responsibility ladder. providing easily-accessible emergency contraception is not the cause of that problem, but rather a way to ensure that young girls finish their education and achieve their full potential rather than being teenage mothers and never getting another chance.

Feb 13, 2011 5:24am EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.